Literature DB >> 27715474

Reply to Varghese et al.'s response to Wu et al. - "Cost effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong".

David Bin-Chia Wu1, Kenneth Kwing Chin Lee1, Vivian Wing Yan Lee2, Li-Wen Hong3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27715474      PMCID： PMC5085012          DOI： 10.1080/21645515.2016.1209279

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  23 in total

1.  The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea.

Authors:  Kostantinos Stamboulidis; Despina Chatzaki; Garyfallia Poulakou; Sophia Ioannidou; Evangelia Lebessi; Ioannis Katsarolis; Vana Sypsa; Michael Tsakanikos; Dimitris Kafetzis; Maria N Tsolia
Journal:  Pediatr Infect Dis J       Date:  2011-07       Impact factor: 2.129

2.  Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.

Authors:  Robert Cohen; Corinne Levy; Edouard Bingen; Marc Koskas; Isabelle Nave; Emmanuelle Varon
Journal:  Pediatr Infect Dis J       Date:  2012-03       Impact factor: 2.129

Review 3.  Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

Authors:  William P Hausdorff; Bernard Hoet; Lode Schuerman
Journal:  BMC Pediatr       Date:  2010-02-02       Impact factor: 2.125

4.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

Review 5.  Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.

Authors:  Stephanie M Davis; Maria Deloria-Knoll; Hilina T Kassa; Katherine L O'Brien
Journal:  Vaccine       Date:  2013-05-16       Impact factor: 3.641

6.  Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population.

Authors:  Ron Dagan; Noga Givon-Lavi; Eugene Leibovitz; David Greenberg; Nurith Porat
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

7.  Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations.

Authors:  M Hackel; C Lascols; S Bouchillon; B Hilton; D Morgenstern; J Purdy
Journal:  Vaccine       Date:  2013-08-06       Impact factor: 3.641

8.  Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study.

Authors:  Carla Magda Allan S Domingues; Jennifer R Verani; Ernesto Issac Montenegro Renoiner; Maria Cristina de Cunto Brandileone; Brendan Flannery; Lucia Helena de Oliveira; João Barberino Santos; José Cássio de Moraes
Journal:  Lancet Respir Med       Date:  2014-04-10       Impact factor: 30.700

9.  Streptococcus pneumoniae serotype 19A in children, South Korea.

Authors:  Eun Hwa Choi; So Hee Kim; Byung Wook Eun; Sun Jung Kim; Nam Hee Kim; Jina Lee; Hoan Jong Lee
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.

Authors:  Miguel W Tregnaghi; Xavier Sáez-Llorens; Pio López; Hector Abate; Enrique Smith; Adriana Pósleman; Arlene Calvo; Digna Wong; Carlos Cortes-Barbosa; Ana Ceballos; Marcelo Tregnaghi; Alexandra Sierra; Mirna Rodriguez; Marisol Troitiño; Carlos Carabajal; Andrea Falaschi; Ana Leandro; Maria Mercedes Castrejón; Alejandro Lepetic; Patricia Lommel; William P Hausdorff; Dorota Borys; Javier Ruiz Guiñazú; Eduardo Ortega-Barría; Juan P Yarzábal; Lode Schuerman
Journal:  PLoS Med       Date:  2014-06-03       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.